| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.7 | 0.007 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |